Cargando…
P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642065/ http://dx.doi.org/10.1097/01.HS9.0000891020.48573.90 |
| _version_ | 1784826223530082304 |
|---|---|
| author | Zerbi, Caterina Lazic, Tanja Sciarra, Roberta Cristinelli, Caterina Mazzacane, Alessandro Carpi, Federico Ferretti, Virginia Valeria Gambini, Giulia Bonfichi, Maurizio Arcaini, Luca Gotti, Manuel |
| author_facet | Zerbi, Caterina Lazic, Tanja Sciarra, Roberta Cristinelli, Caterina Mazzacane, Alessandro Carpi, Federico Ferretti, Virginia Valeria Gambini, Giulia Bonfichi, Maurizio Arcaini, Luca Gotti, Manuel |
| author_sort | Zerbi, Caterina |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9642065 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96420652022-11-14 P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report Zerbi, Caterina Lazic, Tanja Sciarra, Roberta Cristinelli, Caterina Mazzacane, Alessandro Carpi, Federico Ferretti, Virginia Valeria Gambini, Giulia Bonfichi, Maurizio Arcaini, Luca Gotti, Manuel Hemasphere Relapsed/Refractory Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9642065/ http://dx.doi.org/10.1097/01.HS9.0000891020.48573.90 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Relapsed/Refractory Zerbi, Caterina Lazic, Tanja Sciarra, Roberta Cristinelli, Caterina Mazzacane, Alessandro Carpi, Federico Ferretti, Virginia Valeria Gambini, Giulia Bonfichi, Maurizio Arcaini, Luca Gotti, Manuel P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report |
| title | P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report |
| title_full | P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report |
| title_fullStr | P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report |
| title_full_unstemmed | P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report |
| title_short | P113: Promising results with anti-PD-1 therapy in primary refractory Hodgkin lymphoma: a single-centre report |
| title_sort | p113: promising results with anti-pd-1 therapy in primary refractory hodgkin lymphoma: a single-centre report |
| topic | Relapsed/Refractory |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9642065/ http://dx.doi.org/10.1097/01.HS9.0000891020.48573.90 |
| work_keys_str_mv | AT zerbicaterina p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT lazictanja p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT sciarraroberta p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT cristinellicaterina p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT mazzacanealessandro p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT carpifederico p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT ferrettivirginiavaleria p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT gambinigiulia p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT bonfichimaurizio p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT arcainiluca p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport AT gottimanuel p113promisingresultswithantipd1therapyinprimaryrefractoryhodgkinlymphomaasinglecentrereport |